These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24699857)

  • 1. Effects of selective phosphodiesterases-4 inhibitors on learning and memory: a review of recent research.
    Peng S; Sun H; Zhang X; Liu G; Wang G
    Cell Biochem Biophys; 2014 Sep; 70(1):83-5. PubMed ID: 24699857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats.
    Jabaris SG; Sumathy H; Kumar RS; Narayanan S; Thanikachalam S; Babu CS
    Eur J Pharmacol; 2015 Jan; 746():138-47. PubMed ID: 25446433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDE4D inhibitors: a potential strategy for the treatment of memory impairment?
    Bruno O; Ricciarelli R; Prickaerts J; Parker L; Fedele E
    Neuropharmacology; 2014 Oct; 85():290-2. PubMed ID: 24942130
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphodiesterase isoenzymes in the human urethra: a molecular biology and functional study.
    Kedia GT; Oelke M; Sonnenberg JE; Sohn M; Bannowsky A; Kuczyk MA; Ückert S
    Eur J Pharmacol; 2014 Oct; 741():330-5. PubMed ID: 25160741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDE4 as a target for cognition enhancement.
    Richter W; Menniti FS; Zhang HT; Conti M
    Expert Opin Ther Targets; 2013 Sep; 17(9):1011-27. PubMed ID: 23883342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of new 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine analogs as potential phosphodiesterase-4 inhibitors in NIH-3T3 mouse fibroblastic cells.
    Baeeri M; Foroumadi A; Motamedi M; Yahya-Meymandi A; Firoozpour L; Ostad SN; Shafiee A; Souzangarzadeh S; Abdollahi M
    Chem Biol Drug Des; 2011 Sep; 78(3):438-44. PubMed ID: 21722319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting phosphodiesterase 4 as a therapeutic strategy for cognitive improvement.
    Wei X; Yu G; Shen H; Luo Y; Shang T; Shen R; Xi M; Sun H
    Bioorg Chem; 2023 Jan; 130():106278. PubMed ID: 36413930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of PDE IV inhibitors. First asymmetric synthesis of two of GlaxoSmithKline's highly potent Rolipram analogues.
    Zhmurov PA; Sukhorukov AY; Chupakhin VI; Khomutova YV; Ioffe SL; Tartakovsky VA
    Org Biomol Chem; 2013 Dec; 11(46):8082-91. PubMed ID: 24169629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease.
    Giralt A; Saavedra A; Carretón O; Xifró X; Alberch J; Pérez-Navarro E
    Hum Mol Genet; 2011 Nov; 20(21):4232-47. PubMed ID: 21835884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment.
    Brullo C; Ricciarelli R; Prickaerts J; Arancio O; Massa M; Rotolo C; Romussi A; Rebosio C; Marengo B; Pronzato MA; van Hagen BTJ; van Goethem NP; D'Ursi P; Orro A; Milanesi L; Guariento S; Cichero E; Fossa P; Fedele E; Bruno O
    Eur J Med Chem; 2016 Nov; 124():82-102. PubMed ID: 27560284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer's disease.
    Ricciarelli R; Brullo C; Prickaerts J; Arancio O; Villa C; Rebosio C; Calcagno E; Balbi M; van Hagen BT; Argyrousi EK; Zhang H; Pronzato MA; Bruno O; Fedele E
    Sci Rep; 2017 Apr; 7():46320. PubMed ID: 28402318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase Type 4 Inhibition in CNS Diseases.
    Blokland A; Heckman P; Vanmierlo T; Schreiber R; Paes D; Prickaerts J
    Trends Pharmacol Sci; 2019 Dec; 40(12):971-985. PubMed ID: 31704172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the Development of Phosphodiesterase-4 Inhibitors.
    Peng T; Qi B; He J; Ke H; Shi J
    J Med Chem; 2020 Oct; 63(19):10594-10617. PubMed ID: 32255344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
    Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice.
    Zhang C; Xu Y; Chowdhary A; Fox D; Gurney ME; Zhang HT; Auerbach BD; Salvi RJ; Yang M; Li G; O'Donnell JM
    Neuropsychopharmacology; 2018 Oct; 43(11):2299-2309. PubMed ID: 30131563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the cellular activity of PDE 4 inhibitors using two novel PDE 4 reporter cell lines.
    Wunder F; Quednau R; Geerts A; Barg M; Tersteegen A
    Mol Pharm; 2013 Oct; 10(10):3697-705. PubMed ID: 23987244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue.
    Uckert S; Sormes M; Kedia G; Scheller F; Knapp WH; Jonas U; Stief CG
    Urology; 2008 Mar; 71(3):526-30. PubMed ID: 18342202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats.
    Rutten K; Van Donkelaar EL; Ferrington L; Blokland A; Bollen E; Steinbusch HW; Kelly PA; Prickaerts JH
    Neuropsychopharmacology; 2009 Jul; 34(8):1914-25. PubMed ID: 19262466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effective dibenzo[b,d]furan-1-yl-thiazoles as novel PDE-4 inhibitors.
    Balasubramanian G; Narayanan S; Andiappan L; Sappanimuthu T; Thirunavukkarasu S; Sundaram S; Natarajan S; Sivaraman N; Rajagopal S; Nazumudeen FAA; Saxena S; Vishwakarma SL; Narayanan S; Sharma GVR; Srinivasan CV; Kilambi N
    Bioorg Med Chem; 2016 Nov; 24(22):5702-5716. PubMed ID: 27713015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
    Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
    Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.